| Product Code: ETC8697249 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Oman Pharmacogenetic Testing Market Overview |
3.1 Oman Country Macro Economic Indicators |
3.2 Oman Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Oman Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Oman Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Oman Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Oman Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Oman Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Oman Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Oman Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Oman Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Oman Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Oman Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits among healthcare professionals and patients. |
4.2.2 Growing demand for more precise and effective treatment options. |
4.2.3 Government initiatives to promote precision medicine and pharmacogenetic testing in Oman. |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals to interpret and implement pharmacogenetic testing results. |
4.3.2 High initial costs associated with implementing pharmacogenetic testing procedures. |
4.3.3 Regulatory challenges and uncertainties surrounding the use of genetic data in healthcare. |
5 Oman Pharmacogenetic Testing Market Trends |
6 Oman Pharmacogenetic Testing Market, By Types |
6.1 Oman Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Oman Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Oman Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Oman Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Oman Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Oman Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Oman Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Oman Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Oman Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Oman Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Oman Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Oman Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Oman Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Oman Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Oman Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Oman Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Oman Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Oman Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Oman Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Oman Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Oman Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Oman Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Oman Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Oman Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Oman Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Oman Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Oman Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Oman Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Oman Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Oman Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Oman Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Oman Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Oman Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Oman Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Oman Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Oman Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Oman Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Oman Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Oman Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Oman Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Oman Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Oman Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Oman Pharmacogenetic Testing Market Export to Major Countries |
7.2 Oman Pharmacogenetic Testing Market Imports from Major Countries |
8 Oman Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in pharmacogenetic testing. |
8.2 Adoption rate of pharmacogenetic testing in healthcare facilities. |
8.3 Patient satisfaction and outcomes improvement post pharmacogenetic testing. |
8.4 Number of government initiatives supporting precision medicine and pharmacogenetic testing. |
8.5 Research and development investments in pharmacogenetic testing technologies. |
9 Oman Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Oman Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Oman Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Oman Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Oman Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Oman Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Oman Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Oman Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Oman Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Oman Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Oman Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here